| Cell line name |
VACO 235 |
|---|
| Synonyms |
VACO235; VACO-235; V235 |
|---|
| Accession |
CVCL_5175 |
|---|
| Resource Identification Initiative |
To cite this cell line use: VACO 235 (RRID:CVCL_5175) |
|---|
| Comments |
Derived from site: In situ; Colon; UBERON=UBERON_0001155. |
|---|
| Sequence variations |
|
|---|
| Disease |
Colon carcinoma (NCIt: C4910) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Children:
|
|---|
| Sex of cell |
Female |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=3567899
James K.V. Willson, Gerard N. Bittner, Terry DeWayne Oberley, Lorraine Faxon Meisner, James L. Weese;
Cell culture of human colon adenomas and carcinomas.
Cancer Res. 47:2704-2713(1987) PubMed=2253215
Suzanne J. Baker, Antonette C. Preisinger, John Milburn Jessup, Christos Paraskeva, Sanford David Markowitz, James K.V. Willson, Stanley R. Hamilton, Bert Vogelstein;
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
Cancer Res. 50:7717-7722(1990) PubMed=8132740; DOI=10.1172/JCI117048; PMCID=PMC294021
Sanford David Markowitz, Lois Lemmermann Myeroff, Mark J. Cooper, June L. Traicoff, Mary E. Kochera, James D. Lutterbaugh, Margaret Swiriduk, James K.V. Willson;
A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.
J. Clin. Invest. 93:1005-1013(1994) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
ColonAtlas; VACO235
|
|---|
| Encyclopedic resources |
Wikidata; Q54992697
|
|---|
| Polymorphism and mutation databases |
Cosmic; 736333
Cosmic; 956085
IARC_TP53; 23619
|
|---|
| Entry history |
|---|
| Entry creation | 04-Apr-2012 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 14 |
|---|
